Hopefully the ad recovery will continue and help stem more losses.

FORBES: So, is the Media Rebound for Real?

Hopefully the reports of these clinical trials will convince the big pharmas to look for alternative strategies to combat dementia in AD.

FORBES: Eli Lilly Alzheimer's Disease Failure Bolsters Amyloid Theory Skeptics